90 related articles for article (PubMed ID: 11115595)
1. Extended staging results from the detection of isolated tumor cells in the liver of colorectal cancer patients.
Schimanski CC; Linnemann U; Arbogast R; Berger MR
Oncol Rep; 2001; 8(1):185-8. PubMed ID: 11115595
[TBL] [Abstract][Full Text] [Related]
2. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
4. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
Dieterle CP; Conzelmann M; Linnemann U; Berger MR
Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
[TBL] [Abstract][Full Text] [Related]
5. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?
Conzelmann M; Linnemann U; Berger MR
Int J Colorectal Dis; 2005 Mar; 20(2):137-46. PubMed ID: 15459772
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
[TBL] [Abstract][Full Text] [Related]
9. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
Kato M; Ito Y; Kobayashi S; Isono K
Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
12. K-ras status does not predict successful hepatic resection of colorectal cancer metastasis.
Kastrinakis WV; Ramchurren N; Maggard M; Steele G; Summerhayes IC
Arch Surg; 1995 Jan; 130(1):9-14. PubMed ID: 7802584
[TBL] [Abstract][Full Text] [Related]
13. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
[TBL] [Abstract][Full Text] [Related]
15. K-ras gene mutation status in colorectal cancer: comparative analysis of pyrosequencing and PCR-RFLP.
Dobre M; Comănescu M; Arsene D; Iosif C; Bussolati G
Rom J Morphol Embryol; 2013; 54(3):567-74. PubMed ID: 24068405
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations.
Linnemann U; Schimanski CC; Gebhardt C; Berger MR
Int J Colorectal Dis; 2004 Jul; 19(4):380-6. PubMed ID: 14634776
[TBL] [Abstract][Full Text] [Related]
17. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
[TBL] [Abstract][Full Text] [Related]
18. Ras oncogene activation in benign and malignant colorectal tumours.
Spandidos DA; Glarakis IS; Kotsinas A; Ergazaki M; Kiaris H
Tumori; 1995; 81(3 Suppl):7-11. PubMed ID: 7571058
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
[TBL] [Abstract][Full Text] [Related]
20. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]